Nine Seeger Weiss Partners Honored by Lawdragon as Leading Plaintiff Consumer Lawyers

Seeger Weiss LLP is proud to announce that nine of the firm’s partners –  Chris Seeger, Stephen Weiss, David Buchanan, Diogenes Kekatos, Jeffrey Grand, Jennifer Scullion, Parvin Aminolroaya, Shauna Itri, and Christopher Ayers – were chosen by Lawdragon for its 2022 Lawdragon 500 Leading Plaintiff Consumer Lawyers list. Chosen amongst thousands of lawyers, Lawdragon states that […]

April 21, 2022

2022 Lawdragon 500 Leading Plaintiff Consumer Lawyers

Seeger Weiss LLP is proud to announce that nine of the firm’s partners –  Chris Seeger, Stephen Weiss, David Buchanan, Diogenes Kekatos, Jeffrey Grand, Jennifer Scullion, Parvin Aminolroaya, Shauna Itri, and Christopher Ayers – were chosen by Lawdragon for its 2022 Lawdragon 500 Leading Plaintiff Consumer Lawyers list. Chosen amongst thousands of lawyers, Lawdragon states that these lawyers “relish their role of underdog, taking on the toughest cases.”

Co-founding partners Chris Seeger and Stephen Weiss, as well as partners Dave Buchanan and Parvin Aminolroaya, have appeared on the Leading Plaintiff Consumer Lawyers list every year since the list was regularly published in 2019. Diogenes Kekatos and Jeff Grand are 3-time recipients of the honor, and Jennifer Scullion, Shauna Itri, and Chris Ayers have been selected for the list for the first time in this year’s edition.  

This honor follows several Seeger Weiss partners earlier this year being named to Lawdragon’s 2022 Leading Lawyers in America

This guide, first published in 2007 by Lawdragon Inc., presents Lawdragon’s opinion of “the best of the U.S. plaintiff bar who specialize in representing individuals who have suffered injuries from accidents, pharmaceuticals, civil rights abuse and other torts.” Lawdragon’s selection methodology is based on a combination of objective criteria including research of top verdicts and settlements, peer recognition, and interviews with lawyers throughout the country. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More